Trial Profile
Dose finding study of Campath-1H in haploidentical HLA-mismatched hematopoietic stem cell transplantation for hematological malignancies.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 11 Sep 2012
Price :
$35
*
At a glance
- Drugs Alemtuzumab (Primary)
- Indications Graft-versus-host disease; Haematological malignancies
- Focus Therapeutic Use
- 19 Jan 2012 New trial record